Schedule 13G ownership disclosure

MARINUS PHARMACEUTICALS INC

Common Stock · CUSIP: 56854Q200

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Panacea Venture Healthcare Fund II, L.P.

    Shares: 0 · Class: 0%

  • Panacea Venture Healthcare Fund II GP Company, Ltd.

    Shares: 0 · Class: 0%

  • Panacea Innovation Limited

    Shares: 0 · Class: 0%

  • James Huang

    Shares: 0 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-021289
Form type
SCHEDULE 13G/A
Filer
MARINUS PHARMACEUTICALS, INC.
CIK
CIK 1267813
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub